Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel
| Image |  |
|---|---|
| Description | scientific article published on 16 October 2018 |
| Author/s |
author: Kazuhiro Araki Yoshinori Ito Shinji Ohno |
| Publication date | October 16, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |